Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity

Recruiting

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

Trial locations(1 site)

France

CHU Clermont-Ferrand, Clermont-Ferrand

Sponsor

University Hospital, Clermont-Ferrand

Enrollment target

~20 participants

Started

January 2026

Primary completion

January 2029

Age range

18 Years and older

Sex

Male only

Last updated on clinicaltrials.gov in March 2026.

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Lise LACLAUTRE

University Hospital, Clermont-Ferrand